Author:
Shaikh Nissar,Nahid Seema,Ummunnisa Firdous,Fatima Ifrah,Hilani Mohamad,Gul Asma,Al Basha A.,Yahia W.,Al Hail F.,Elfil H.,Abdalla E.,Nainthramveetil M.M.,Imraan M.A,Zubair Muhammad,Khan Sibghatulla,Korichi N.,Alkhawaga S.,Ismail H.,Yaqoob S.,Abdulrahman M.S. Al Khelaifi Mashael
Abstract
Preeclampsia is a hypertensive disorder of pregnancy affecting 6–12% of the population. There are various risk factors for the development of preeclampsia, ranging from advanced maternal age to genetics. The proposed etiologies for preeclampsia are abnormal placentation, immunological intolerance, endothelial damage, and genetic inheritance. The pathogenesis includes endothelial activation and dysfunction leading to vasospasm. Preeclampsia is divided into two stages: asymptomatic and symptomatic stages. Preeclampsia causes multiple organ involvement, namely central nervous system, respiratory, cardiovascular, hematological dysfunction, HELLP (hemolysis elevated liver enzymes, low platelets) syndrome, endocrine, renal, hepatic, and uteroplacental dysfunction. These organ dysfunctions increase morbidity and mortality in preeclamptic pregnant patients.